Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
12/2003
12/18/2003CA2488567A1 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
12/18/2003CA2488213A1 Ligand and complex for catalytically bleaching a substrate
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2476599A1 Ligand and complex for catalytically bleaching a substrate
12/17/2003EP1371652A1 Europium compounds and ink compositions containing the same
12/17/2003EP1370682A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
12/17/2003EP1370559A1 Triazolopyridines as anti-inflammatory agents
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370554A1 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
12/17/2003EP1370549A1 Methods for the preparation of mirtazapine intermediates
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370515A2 Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
12/17/2003EP1370301A2 Actinium-225 complexes and conjugates for targeted radiotherapy
12/17/2003EP1370261A2 New use
12/17/2003EP1218380B1 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
12/17/2003EP1162970B1 Anti-inflammatory uses of manzamines
12/17/2003EP0937075B1 New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
12/17/2003CN1462303A Double-spiro organic compounds and electric-field luminescent devices
12/17/2003CN1462273A Bicyclic heteroaromatic compounds
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/17/2003CN1462193A Oral preparations
12/17/2003CN1131229C Salt of naphthyridine carboxylic acid derivative
12/17/2003CN1131215C Cyclic and heterocyclic n-substituted 'alpha'-iminoh-ydroxamic acid and carboxylic acids
12/16/2003US6664462 Dye having high light absorbance over a wide wavelength range; containing 2,2'-bipyridine or 1,10-phenanthroline ligands
12/16/2003US6664421 Process for preparing zolpidem
12/16/2003US6664396 One step synthesis for quinacridone compounds
12/16/2003US6664268 Crystal modification B of 8-cyano-1-cyclopropyl-7-(1S,6S-2, 8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
12/16/2003US6664265 Imidazo(4,5-c)quinoline-4-amines; inducing cytokine biosynthesis; viral and neoplastic disease treatment
12/16/2003US6664264 Thioether substituted imidazoquinolines
12/16/2003US6664263 1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity
12/16/2003US6664260 Heterocyclic ether substituted imidazoquinolines
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003CA2093125C Angiotensin ii antagonists
12/11/2003WO2003101994A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
12/11/2003WO2003101990A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
12/11/2003WO2003101989A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003WO2003101988A2 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
12/11/2003WO2003101985A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003WO2003101983A1 Tetrahydropyran derivative
12/11/2003WO2003101981A1 Novel substituted indoles
12/11/2003WO2003101968A1 Pyrazole compound and medicinal composition containing the same
12/11/2003WO2003101953A2 Triazaspiro compounds useful for treating or preventing pain
12/11/2003WO2003101949A2 Process for imidazo[4,5-c]pyridin-4-amines
12/11/2003WO2003101933A1 Intermediate products, methods for their preparation and use thereof
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2003101442A1 Peptide deformylase inhibitors
12/11/2003WO2003087090A3 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
12/11/2003WO2003078392A3 Process for preparing crystalline form i of cabergoline
12/11/2003WO2003028721A3 Substituted benzimidazole compounds and their use for the treatment of cancer
12/11/2003WO2003024926A3 Methods and compositions of novel triazine compounds
12/11/2003US20030229226 Cathepsin cysteine protease inhibitors
12/11/2003US20030229120 Zinc binding ligand; sustained release of insulin
12/11/2003US20030229116 Enamine derivatives
12/11/2003US20030229113 Keratinocyte growth inhibitors and hydroxamic acid derivatives
12/11/2003US20030229109 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
12/11/2003US20030229104 Substituted 3,4-dihydropyrido[1,2-a]pyrimidines
12/11/2003US20030229100 Anticholesterol agents; antidiabetic agents; hypotensive agents
12/11/2003US20030229098 Polycyclic compounds exhibiting anti-tumor activities
12/11/2003US20030229095 Sexual disorders
12/11/2003US20030229090 Controlling activation of mast cells; antiallergens; antiinflamamtory agents
12/11/2003US20030229089 Cyclic compounds
12/11/2003US20030229084 Osteoporosis; antiarthritic agents
12/11/2003US20030229080 Cardiovascular disorders; sexual disorders
12/11/2003US20030229079 1-(Aromatic- or heteroaromatic-substituted)-3-(heteroaromatic substituted)-1,3-propanediones and uses thereof
12/11/2003US20030229075 Induce immunology response; genetic engineering; gene expression; crystallization
12/11/2003US20030229068 Controlling apoptosis, cell proliferation; strokes; anticancer agents; central nervous system disorders
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders
12/11/2003US20030229026 Agents and methods for the treatment of proliferative diseases
12/11/2003CA2487679A1 Inhibitors of jak and cdk2 protein kinases
12/11/2003CA2487659A1 Intermediate products, methods for their preparation and use thereof
12/11/2003CA2486933A1 Tetrahydropyran derivative
12/11/2003CA2486530A1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
12/11/2003CA2486191A1 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands
12/11/2003CA2482838A1 Pyrazole compounds and pharmaceutical compositions containing the compound
12/11/2003CA2482345A1 Compounds and compositions for the treatment of diabetes and diabetes-related disorders
12/10/2003EP1368378A2 Constitutively desensitized g protein-coupled receptors
12/10/2003EP1368355A2 Substituted pyrazolopyrimidines and thiazolopyrimidines
12/10/2003EP1368342A2 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/10/2003EP1368341A1 Phenyl derivatives 3
12/10/2003EP1368324A1 Quinazolines as mmp-13 inhibitors
12/10/2003EP1368009A2 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
12/10/2003EP1368006A1 Novel modified released formulation
12/10/2003EP1289985B1 Beta-carboline derivatives useful as inhibitors of phosphodiesterase
12/10/2003EP0970086B1 Spiro compounds and the use thereof
12/10/2003EP0935598B1 5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS
12/10/2003EP0901374B1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
12/10/2003CN1130330C Process for preparation of dialkyl succiny/succinates
12/09/2003US6660747 Amido ether substituted imidazoquinolines
12/09/2003US6660740 Sorbitol dehydrogenase inhibitors
12/09/2003US6660736 MAO-B inhibitors
12/09/2003US6660735 Urea substituted imidazoquinoline ethers
12/09/2003US6660731 Pyrazole compounds useful as protein kinase inhibitors
12/09/2003US6660730 Free of lower alcohol insolubles or substantially free of residual solvent; useful in pharmaceuticals
12/09/2003CA2078758C 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
1 ... 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 ... 646